Kim Sigaloff

HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study

Raph L Hamers, Carole L. Wallis, Cissy Kityo et al. · The Lancet Infectious Diseases · 2011 · 289 citations

Epidemiology, Antiretroviral Therapy, Hiv/aids Counselling +12

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

Raph L Hamers, Rob Schuurman, Kim Sigaloff et al. · The Lancet Infectious Diseases · 2011 · 194 citations

Drug-resistance Outcomes, Hiv/aids Counselling, Treatment And Prevention +11

Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa

Kim Sigaloff, Raph L Hamers, Carole L. Wallis et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2011 · 184 citations

Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies

Raph L Hamers, Kim Sigaloff, Annemarie M. J. Wensing et al. · Clinical Infectious Diseases · 2012 · 160 citations · Full text

Clinical features and prognostic factors in Covid-19: A prospective cohort study

Sanne de Bruin, Lieuwe D. J. Bos, Marian A. van Roon et al. · EBioMedicine · 2021 · 135 citations · Full text